BUY Solar Industries India Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))15 May 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·4 May · 2w ago
Solar Industries India Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Updates on Audited Financial Results (Standalone & Consolidated) of the Company for thequarter and year ended on March 31, 2026.".
NSE · Press Release·15 May · 2d ago
Solar Industries India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NSE · Outcome of Board Meeting·15 May · 2d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Solar Industries India
- BUY — Siddharth Rai Mangala16 Oct 2026 · ~2 weeks · target ₹20,600 · SL hit
- BUY — Prakash Gaba13 Oct 2026 · ~2 weeks · target ₹21,000 · SL hit
- BUY — Manas Jaiswal12 Oct 2026 · ~3 months · target ₹22,500 · SL hit
- BUY — Arun Kumar Mantri9 Oct 2026 · Same day · target ₹20,550 · Expired
- BUY — Chandan Taparia, Motilal Oswal30 Sept 2026 · ~2 weeks · target ₹19,500 · Expired
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

